Quest Diagnostics Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $320.0M | $252.0M | $245.0M | $245.0M | $282.0M | $220.0M | $222.0M | $226.0M |
| Depreciation & Amortization | $146.0M | $147.0M | $145.0M | $142.0M | $143.0M | $140.0M | $135.0M | $125.0M |
| Depreciation | $108.0M | $110.0M | $108.0M | $103.0M | $104.0M | $101.0M | $98.0M | $93.0M |
| Amortization | $38.0M | $37.0M | $37.0M | $39.0M | $39.0M | $39.0M | $37.0M | $32.0M |
| Stock-Based Compensation | $23.0M | $20.0M | $25.0M | $20.0M | $21.0M | $22.0M | $27.0M | $19.0M |
| Net Cash from Operating Activities | $597.0M | $278.0M | $465.0M | $563.0M | $544.0M | $314.0M | $464.0M | $356.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $138.0M | $114.0M | $158.0M | $144.0M | $108.0M | $117.0M | $123.0M | $106.0M |
| Business Acquisitions | $0 | $38.0M | $50.0M | $34.0M | $17.0M | $0 | $383.0M | $1.53B |
| Net Cash from Investing Activities | $-134.0M | $-152.0M | $-191.0M | $-201.0M | $-124.0M | $-115.0M | $-502.0M | $-1.63B |
| Financing Activities | ||||||||
| Dividends Paid | $96.0M | $88.0M | $90.0M | $89.0M | $90.0M | $84.0M | $84.0M | $84.0M |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-229.0M | $-152.0M | $-287.0M | $-247.0M | $-293.0M | $-561.0M | $-170.0M | $1.77B |
| Net Change in Cash | $233.0M | $-27.0M | $-12.0M | $113.0M | $131.0M | $-361.0M | $-215.0M | $493.0M |
| Free Cash Flow | $459.0M | $164.0M | $307.0M | $419.0M | $436.0M | $197.0M | $341.0M | $250.0M |